Vir Biotechnology, Inc.

Vir Biotechnology, Inc.verified

VIR

Price:

$7.39

Market Cap:

$1.02B

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with ...[Read more]

Industry

Biotechnology

IPO Date

2019-10-11

Stock Exchange

NASDAQ

Ticker

VIR

The PE Ratio as of December 2024 (TTM) for Vir Biotechnology, Inc. (VIR) is -1.88

According to Vir Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.88. This represents a change of -35.40% compared to the average of -2.91 of the last 4 quarters.

Vir Biotechnology, Inc. (VIR) Historical PE Ratio (quarterly & annually)

How has VIR PE Ratio performed in the past?

The mean historical PE Ratio of Vir Biotechnology, Inc. over the last ten years is -5.00. The current -1.88 PE Ratio has changed 3.66% with respect to the historical average. Over the past ten years (40 quarters), VIR's PE Ratio was at its highest in in the June 2021 quarter at 24.88. The PE Ratio was at its lowest in in the June 2020 quarter at -37.79.

Quarterly (TTM)
Annual

Average

-5.00

Median

-7.75

Minimum

-19.45

Maximum

10.29

Vir Biotechnology, Inc. (VIR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vir Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 37.82%

Maximum Annual PE Ratio = 10.29

Minimum Annual Increase = -196.29%

Minimum Annual PE Ratio = -19.45

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.19-133.72%
20226.51-36.76%
202110.29-196.29%
2020-10.6837.82%
2019-7.75-33.88%
2018-11.72-39.72%

Vir Biotechnology, Inc. (VIR) Average PE Ratio

How has VIR PE Ratio performed in the past?

The current PE Ratio of Vir Biotechnology, Inc. (VIR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

4.87

5-year avg

-0.77

10-year avg

-5.00

Vir Biotechnology, Inc. (VIR) PE Ratio vs. Peers

How is VIR’s PE Ratio compared to its peers?

Vir Biotechnology, Inc.’s PE Ratio is less than CureVac N.V. (5.87), greater than Reata Pharmaceuticals, Inc. (-20.07), less than Krystal Biotech, Inc. (87.02), less than Propanc Biopharma, Inc. (-0.09), greater than IVERIC bio, Inc. (-27.51), greater than Blueprint Medicines Corporation (-44.57), less than Amylyx Pharmaceuticals, Inc. (-1.06), greater than Karuna Therapeutics, Inc. (-37.08), greater than Day One Biopharmaceuticals, Inc. (-14.48), greater than Viking Therapeutics, Inc. (-47.32), greater than Intercept Pharmaceuticals, Inc. (-91.78), greater than Terns Pharmaceuticals, Inc. (-5.08), greater than Akero Therapeutics, Inc. (-8.35), greater than PTC Therapeutics, Inc. (-7.75), greater than Madrigal Pharmaceuticals, Inc. (-13.08),

Build a custom stock screener for Vir Biotechnology, Inc. (VIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vir Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vir Biotechnology, Inc. (VIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vir Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vir Biotechnology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Vir Biotechnology, Inc. (VIR)?

What is the highest PE Ratio for Vir Biotechnology, Inc. (VIR)?

What is the 3-year average PE Ratio for Vir Biotechnology, Inc. (VIR)?

What is the 5-year average PE Ratio for Vir Biotechnology, Inc. (VIR)?

How does the current PE Ratio for Vir Biotechnology, Inc. (VIR) compare to its historical average?